** Shares of Archer Materials AXE.AX rise as much as 13.3% to A$0.34, highest level since February 26
** Semiconductor technology company enters partnership with Hylid Diagnostics to develop an at-home testing device for chronic kidney disease as part of its Biochip project
** About 279,150 shares change hands by 0057 GMT, 1.3 times the 30-day average volume of shares
** Stock down 48.3% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.